Rekombinanta proteiner
Modifierade eller manipulerade proteiner kodade av rekombinant DNA och lämpliga för en mängd olika ändamål, inklusive modifiering av gensekvenser, massproteinproduktion och tillverkning av kommersiella produkter.
Art
- (2)
- (2)
- (6)
- (6)
- (6)
- (6)
- (2)
- (11)
- (1,874)
- (111)
- (1)
- (1)
- (4)
- (51)
- (1)
- (8)
- (2)
- (15)
- (1)
- (458)
- (8)
- (1)
- (1)
- (28,492)
- (1)
- (8)
- (3)
- (15)
- (1)
- (3)
- (13)
- (1)
- (7)
- (1)
- (3)
- (2)
- (3)
- (4)
- (3)
- (2)
- (5)
- (3)
- (3)
- (4)
- (4)
- (2)
- (2)
- (2)
- (1)
- (4)
- (1)
- (30,161)
- (202)
- (27)
- (19)
- (17)
- (8)
- (4)
- (1)
- (3)
- (2)
- (6)
- (218)
- (4)
- (2)
- (1,063)
- (18)
- (2)
- (1)
- (2)
- (14)
- (8)
- (1)
- (53)
- (2)
- (2)
- (2)
- (1)
- (42)
- (13)
- (46)
- (31)
- (2)
- (62)
- (4)
- (165)
- (178)
- (13)
- (12)
- (3)
- (8)
- (4)
- (156)
- (4)
- (3)
- (3)
- (2)
- (2)
- (2)
- (14)
- (30,025)
- (4)
- (4,516)
- (2)
- (4)
För användning med (applikation)
- (1)
- (2,853)
- (1)
- (28,531)
- (1)
- (3)
- (30)
- (65)
- (355)
- (5,938)
- (24)
- (1)
- (8)
- (2)
- (8)
- (21,461)
- (2)
- (4)
- (2)
- (2)
- (13)
- (59)
- (2)
- (2)
- (2)
- (1)
- (2)
- (2)
- (3)
- (3)
- (1)
- (5)
- (1)
- (1)
- (248)
- (23,783)
- (1)
- (16)
- (1)
- (1)
- (28)
- (4)
- (50,532)
- (512)
- (2)
- (4)
- (32)
- (720)
- (6)
- (3)
- (200)
- (1)
- (1)
- (1)
- (126)
- (4,024)
- (1,567)
- (3)
- (62)
- (7)
- (3)
- (4)
- (1)
- (19,645)
- (27)
- (31)
- (19)
- (1)
- (3)
- (179)
- (16)
- (3)
- (116)
- (150)
- (97)
- (2)
- (20)
- (4)
- (1)
- (1,607)
- (2)
- (4)
- (1)
- (18)
- (38)
- (11)
- (2)
- (1)
- (2)
- (1)
- (9)
- (17)
- (2)
- (503)
- (1)
- (4,210)
- (4)
- (1)
- (8)
- (1)
- (1)
- (4)
- (3)
- (1)
- (1)
- (1)
- (1)
- (47,864)
- (198)
- (15)
- (2)
- (1)
- (197)
- (62)
- (6)
- (1)
- (6)
- (22)
- (1)
- (3)
- (6)
- (1)
- (197)
- (1)
- (8,234)
- (6)
- (4)
- (1)
- (13)
- (2)
- (4)
- (11)
- (5)
- (8)
- (1)
- (3)
- (50,352)
- (409)
Rekombinant
- (12)
- (67,844)
- (1)
Form
- (4)
- (19)
- (7)
- (49,941)
- (7,417)
- (3,669)
- (136)
- (17)
- (3,413)
- (5)
Konjugera
- (2)
- (1)
- (66)
- (1)
- (4)
- (2)
- (11)
- (64)
- (1)
- (4)
- (4)
- (1)
- (409)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (4)
- (2)
- (101)
- (12)
- (2)
- (3)
- (2)
- (2)
- (2)
- (1)
- (14)
- (677)
- (1)
- (2)
- (3)
- (46)
- (42,457)
- (1)
- (2)
Filtrerade sökresultat
Produkter från vissa av våra leverantörer visas inte i filtrerade sökresultat. Vänligen
Rensa alla filter
för att se dessa produkter.
Sök på nyckelord:
Rensa sökningen
1
–
15
av
78,821
Resultat
1
| Innehåll och lagring | -20°C |
|---|---|
| Källa | E. coli |
| Rekombinant | Recombinant |
| Form | Lyophilized |
| Biologisk aktivitet | Determined by the dose-dependent stimulation of the proliferation of Balb/c 3T3 cells.The expected ED50 for this effect is 1.0-3.0 ng/ml |
| Endotoxinkoncentration | <1 EU/ μg |
| Vanligt namn | PDGF-BB |
| Gensymbol | PDGFB |
| Namn | Human PDGF-BB |
| Uttryckssystem | E. coli |
| Gene Alias | becaplermin; c-sis; FLJ12858; H-PDGF-BB; IBGC5; PDGF; pdgf protein; PDGF subunit B; PDGF, B chain; PDGF2; PDGF-2; PDGFB; PDGF-B; platelet derived growth factor subunit B; platelet derived growth factor, B polypeptide; platelet-derived growth factor 2; platelet-derived growth factor B; platelet-derived growth factor B chain; platelet-derived growth factor beta; platelet-derived growth factor beta polypeptide; platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog); platelet-derived growth factor subunit B; platelet-derived growth factor, beta polypeptide (oncogene SIS); Platelet-derived growth factor, same as Sis (Simian sarcoma viral oncogene homologue, c-sis); proto-oncogene c-Sis; Sis; SSV |
| Sekvens | SLGSLTIAEP AMIAECKTRT EVFEISRRLI DRTNANFLVW PPCVEVQRCS GCCNNRNVQC RPTQVQLRPV QVRKIEIVRK KPIFKKATVT LEDHLACKCE TVAAARPVT |
| Molekylvikt (g/mol) | 24.3 kDa |
| Regulatorisk status | RUO |
| Formulering | protein with no preservative |
| För användning med (applikation) | ELISA,Functional Assay,Western Blot |
| Konjugera | Unconjugated |
| Renhet eller kvalitetsklass | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Gen-ID (Entrez) | 5155 |
| Tillträdesnummer | P01127 |
2
| Art | Human |
|---|---|
| Form | Lyophilized |
| Proteinform | Recombinant, Ligand |
| Biologisk aktivitet | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Frakt skick | Wet Ice |
| Endotoxinnivå | <0.1 ng/μg |
| Forskningskategori | Stem Cell Research, Oncology |
| Produktlinje | Gibco |
| Vanligt namn | EGF |
| Gensymbol | EGF |
| Namn | Human EGF |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Protein subtyp | EGF (Epidermal Growth Factor) |
| Molekylvikt (g/mol) | 6.2 kDa |
| Regulatorisk status | RUO |
| Produkttyp | Protein |
| Aktivitet | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| För användning med (applikation) | Bioactivity |
| Konjugera | Unconjugated |
| Renhet eller kvalitetsklass | >95% by SDS-PAGE |
| Tillträdesnummer | P01133 |
| Innehåll och lagring | 4°C |
| Förvaringskrav | 4°C |
| Rekombinant | Recombinant |
| Proteinfamilj | Growth Factors & Receptors |
| Klassificering | Carrier-Free |
| Endotoxinkoncentration | <0.1 ng/μg |
| Uttryckssystem | E. coli |
| Reningsmetod | Purified |
| Formulering | Protein with no preservative |
| Gen-ID (Entrez) | 1950 |
3
| Gensymbol | APOE |
|---|---|
| Namn | Human ApoE4 |
| Källa | E. coli |
| Rekombinant | Recombinant |
| Sekvens | MKVEQAVETE PEPELRQQTE WQSGQRWELA LGRFWDYLRW VQTLSEQVQE ELLSSQVTQE LRALMDETMK ELKAYKSELE EQLTPVAEET RARLSKELQA AQARLGADME DVRGRLVQYR GEVQAMLGQS TEELRVRLAS HLRKLRKRLL RDADDLQKRL AVYQAGAREG AERGLSAIRE RLGPLVEQGR VRAATVGSLA GQPLQERAQA WGERLRARME EMGSRTRDRL DEVKEQVAEV RAKLEEQAQQ IRLQAEAFQA RLKSWFEPLV EDMQRQWAGL VEKVQAAVGT SAAPVPSDNH |
| Form | Lyophilized |
| Regulatorisk status | RUO |
| Formulering | Protein with no preservative |
| För användning med (applikation) | Control |
| Konjugera | Unconjugated |
| Renhet eller kvalitetsklass | ≥ 90% by SDS-PAGE gel and HPLC analyses. |
| Gen-ID (Entrez) | 348 |
| Tillträdesnummer | P02649 |
4
Kampanjer är tillgängliga
Gibco™ Human TPO (Thrombopoietin) Recombinant Protein, PeproTech®
![]()
Gibco™ Human TPO (Thrombopoietin) Recombinant Protein, PeproTech®
Recombinant Protein
| Innehåll och lagring | -20°C |
|---|---|
| Källa | E. coli |
| Rekombinant | Recombinant |
| Form | Lyophilized |
| Biologisk aktivitet | The ED50 as determined by the dose-dependent stimulation of the proliferation of human MO7e cells was found to be ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Endotoxinkoncentration | <1 EU/ μg |
| Vanligt namn | Thrombopoietin |
| Gensymbol | THPO |
| Namn | Human TPO (Thrombopoietin) |
| Uttryckssystem | E. coli |
| Gene Alias | C-mpl ligand; Megakaryocyte colony-stimulating factor; megakaryocyte growth and development factor; megakaryocyte stimulating factor; Mgdf; MKCSF; ML; MPL ligand; Mpllg; MSA; Myeloproliferative leukemia virus oncogene ligand; prepro-thrombopoietin; TDH2A; THCYT1; THPO; Thrombopoietin; thyroid microsomal antigen; thyroid peroxidase; thyroperoxidase; Tpo; TPX |
| Sekvens | SPAPPACDLR VLSKLLRDSH VLHSRLSQCP EVHPLPTPVL LPAVDFSLGE WKTQMEETKA QDILGAVTLL LEGVMAARGQ LGPTCLSSLL GQLSGQVRLL LGALQSLLGT QLPPQGRTTA HKDPNAIFLS FQHLLRGKVR FLMLVGGSTL CVRRAPPTTA VPSRTSLVLT LNEL |
| Molekylvikt (g/mol) | 18.6 kDa |
| Regulatorisk status | RUO |
| Formulering | protein with no preservative |
| För användning med (applikation) | ELISA,Functional Assay,Western Blot |
| Konjugera | Unconjugated |
| Renhet eller kvalitetsklass | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Gen-ID (Entrez) | 7066 |
| Tillträdesnummer | P40225 |
5
| Innehåll och lagring | -20°C |
|---|---|
| Källa | E. coli |
| Rekombinant | Recombinant |
| Form | Lyophilized |
| Biologisk aktivitet | The ED50 was determined by the dose-dependent stimulation of the proliferation of murine M-NSF-60 cells ≤ 1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Endotoxinkoncentration | <1 EU/ μg |
| Vanligt namn | M-CSF |
| Gensymbol | Csf1 |
| Namn | Human M-CSF |
| Uttryckssystem | E. coli |
| Gene Alias | C87615; colony stimulating factor 1; colony stimulating factor 1 (macrophage); colony-stimulating factor-1 splice variant; CSF1; CSF-1; Csfm; H-MCSF; lanimostim; macrophage colony stimulating factor 1; macrophage colony stimulating factor alpha; macrophage colony stimulating factor beta; macrophage colony-stimulating factor; macrophage colony-stimulating factor 1; macrophage colony-stimulating factor beta; macrophage-colony stimulating factor alpha; MCSF; MCSF alpha; MCSFBETA; MGC31930; M-MCSF; op; osteopetrosis; Processed macrophage colony-stimulating factor 1 |
| Sekvens | MEEVSEYCSH MIGSGHLQSL QRLIDSQMET SCQITFEFVD QEQLKDPVCY LKKAFLLVQD IMEDTMRFRD NTPNAIAIVQ LQELSLRLKS CFTKDYEEHD KACVRTFYET PLQLLEKVKN VFNETKNLLD KDWNIFSKNC NNSFAECSSQ GHERQSEGS |
| Molekylvikt (g/mol) | 36.8 kDa |
| Regulatorisk status | RUO |
| Formulering | protein with no preservative |
| För användning med (applikation) | ELISA,Functional Assay,Western Blot |
| Konjugera | Unconjugated |
| Renhet eller kvalitetsklass | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Gen-ID (Entrez) | 1435 |
| Tillträdesnummer | P09603 |
6
| Innehåll och lagring | -20°C |
|---|---|
| Källa | E. coli |
| Rekombinant | Recombinant |
| Form | Lyophilized |
| Biologisk aktivitet | The ED50 was determined by a cell proliferation assay using FDC-P1 cells is ≤ 2.0 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg |
| Endotoxinkoncentration | <1 EU/ μg |
| Vanligt namn | IGF1 |
| Gensymbol | IGF1 |
| Namn | Human IGF-I |
| Uttryckssystem | E. coli |
| Gene Alias | C730016P09Rik; class 1 insulin-like growth factor I preproprotein; class 2 insulin-like growth factor I preproprotein; H-IGF-1; IBP1; IGF; IGF1; Igf-1; IGF1A; IGFI; Igf-I; IGFIa; IGF-IA; IGF-IB; insulin growth factor-1; Insulin like growth factor; insulin like growth factor 1; insulin-like growth factor 1; insulin-like growth factor 1 (somatomedin C); insulin-like growth factor I; insulin-like growth factor I (somatomedin C); insulin-like growth factor IB; mechano growth factor; MGF; M-IGF-1; OTTHUMP00000195084; prepro-IGF-I; prepro-insulin-like growth factor I; R-IGF-1; somatomedin; Somatomedin C; Somatomedin-C |
| Sekvens | GPETLCGAEL VDALQFVCGD RGFYFNKPTG YGSSSRRAPQ TGIVDECCFR SCDLRRLEMY CAPLKPAKSA |
| Molekylvikt (g/mol) | 7.6 kDa |
| Regulatorisk status | RUO |
| Formulering | protein with no preservative |
| För användning med (applikation) | ELISA,Functional Assay,Western Blot |
| Konjugera | Unconjugated |
| Renhet eller kvalitetsklass | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Gen-ID (Entrez) | 3479 |
| Tillträdesnummer | P05019 |
7
| Innehåll och lagring | -20°C |
|---|---|
| Källa | E. coli |
| Rekombinant | Recombinant |
| Form | Lyophilized |
| Biologisk aktivitet | Determined by the dose-dependent stimulation of the proliferation of human TF-1 cells. The expected ED50 is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Endotoxinkoncentration | <1 EU/ μg |
| Vanligt namn | NGF |
| Gensymbol | NGF |
| Namn | Human beta-NGF |
| Uttryckssystem | E. coli |
| Gene Alias | B nerve growth factor; beta ngf; beta-nerve growth factor; BetaNGF; beta-NGF; bNGF; b-NGF; HSAN5; MGC161426; MGC161428; nerve growth factor; nerve growth factor (beta polypeptide); nerve growth factor, beta; nerve growth factor, beta polypeptide; nerve growth factor, beta subunit; NGF; NGF b; NGF β; Ngfb; NGFbeta; NGFβ; β nerve growth factor; β NGF; βNGF |
| Sekvens | SSSHPIFHRG EFSVCDSVSV WVGDKTTATD IKGKEVMVLG EVNINNSVFK QYFFETKCRD PNPVDSGCRG IDSKHWNSYC TTTHTFVKAL TMDGKQAAWR FIRIDTACVC VLSRKAVRRA |
| Molekylvikt (g/mol) | 27 kDa |
| Regulatorisk status | RUO |
| Formulering | protein with no preservative |
| För användning med (applikation) | ELISA,Functional Assay,Western Blot |
| Konjugera | Unconjugated |
| Renhet eller kvalitetsklass | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Gen-ID (Entrez) | 4803 |
| Tillträdesnummer | P01138 |
8
| Innehåll och lagring | -20°C |
|---|---|
| Källa | E. coli |
| Rekombinant | Recombinant |
| Form | Lyophilized |
| Biologisk aktivitet | The ED50 as determined by the dose-dependent stimulation of the proliferation of M-NFS-60 cells is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Endotoxinkoncentration | <1 EU/ μg |
| Vanligt namn | M-CSF |
| Gensymbol | Csf1 |
| Namn | Mouse M-CSF |
| Uttryckssystem | E. coli |
| Gene Alias | C87615; colony stimulating factor 1; colony stimulating factor 1 (macrophage); colony-stimulating factor-1 splice variant; CSF1; CSF-1; Csfm; H-MCSF; lanimostim; macrophage colony stimulating factor 1; macrophage colony stimulating factor alpha; macrophage colony stimulating factor beta; macrophage colony-stimulating factor; macrophage colony-stimulating factor 1; macrophage colony-stimulating factor beta; macrophage-colony stimulating factor alpha; MCSF; MCSF alpha; MCSFBETA; MGC31930; M-MCSF; op; osteopetrosis; Processed macrophage colony-stimulating factor 1 |
| Sekvens | MKEVSEHCSH MIGNGHLKVL QQLIDSQMET SCQIAFEFVD QEQLDDPVCY LKKAFFLVQD IIDETMRFKD NTPNANATER LQELSNNLNS CFTKDYEEQN KACVRTFHET PLQLLEKIKN FFNETKNLLE KDWNIFTKNC NNSFAKCSSR DVVTKP |
| Molekylvikt (g/mol) | 36.4 kDa |
| Regulatorisk status | RUO |
| Formulering | protein with no preservative |
| För användning med (applikation) | ELISA,Functional Assay,Western Blot |
| Konjugera | Unconjugated |
| Renhet eller kvalitetsklass | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Gen-ID (Entrez) | 12977 |
| Tillträdesnummer | P07141 |
9
| Innehåll och lagring | -20°C |
|---|---|
| Källa | E. coli |
| Rekombinant | Recombinant |
| Form | Lyophilized |
| Biologisk aktivitet | The ED50 was determined a cell proliferation assay using FDC-P1 cells is ≤ 2.0 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg |
| Endotoxinkoncentration | <1 EU/ μg |
| Vanligt namn | IGF1 |
| Gensymbol | IGF1 |
| Namn | Mouse IGF-I |
| Uttryckssystem | E. coli |
| Gene Alias | C730016P09Rik; class 1 insulin-like growth factor I preproprotein; class 2 insulin-like growth factor I preproprotein; H-IGF-1; IBP1; IGF; IGF1; Igf-1; IGF1A; IGFI; Igf-I; IGFIa; IGF-IA; IGF-IB; insulin growth factor-1; Insulin like growth factor; insulin like growth factor 1; insulin-like growth factor 1; insulin-like growth factor 1 (somatomedin C); insulin-like growth factor I; insulin-like growth factor I (somatomedin C); insulin-like growth factor IB; mechano growth factor; MGF; M-IGF-1; OTTHUMP00000195084; prepro-IGF-I; prepro-insulin-like growth factor I; R-IGF-1; somatomedin; Somatomedin C; Somatomedin-C |
| Sekvens | GPETLCGAEL VDALQFVCGP RGFYFNKPTG YGSSIRRAPQ TGIVDECCFR SCDLRRLEMY CAPLKPTKAA |
| Molekylvikt (g/mol) | 7.6 kDa |
| Regulatorisk status | RUO |
| Formulering | protein with no preservative |
| För användning med (applikation) | ELISA,Functional Assay,Western Blot |
| Konjugera | Unconjugated |
| Renhet eller kvalitetsklass | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Gen-ID (Entrez) | 16000 |
| Tillträdesnummer | P05017 |
10
| Innehåll och lagring | -20°C |
|---|---|
| Källa | E. coli |
| Rekombinant | Recombinant |
| Form | Lyophilized |
| Biologisk aktivitet | The ED50 as determined by the cytolysis of murine L929 cells in the presence of actinomycin D is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Endotoxinkoncentration | <1 EU/ μg |
| Vanligt namn | TNF alpha |
| Gensymbol | Tnf |
| Namn | Mouse TNF-alpha |
| Uttryckssystem | E. coli |
| Gene Alias | APC1 protein; Cachectin; C-domain 1; C-domain 2; cTNF; DADB-70P7.1; DIF; ICD1; ICD2; Intracellular domain 1; Intracellular domain 2; N-terminal fragment; NTF; RATTNF; Tnf; TNF alpha; TNF superfamily; TNF a; TNF, macrophage-derived; TNF, monocyte-derived; TNFA; TNF-a; TNFalpha; TNF-alpha; Tnfsf1a; TNFSF2; TNFa; TNLG1F; Tumor necrosis factor; tumor necrosis factor (TNF superfamily, member 2); tumor necrosis factor alpha; tumor necrosis factor alpha (cachetin); tumor necrosis factor alpha precursor; tumor necrosis factor ligand 1 F; tumor necrosis factor ligand superfamily member 2; Tumor necrosis factor, membrane form; Tumor necrosis factor, soluble form; tumor necrosis factor-alpha; tumor necrosis factor-alpha precursor; tumor-necrosis factor; tumour necrosis factor |
| Sekvens | MLRSSSQNSS DKPVAHVVAN HQVEEQLEWL SQRANALLAN GMDLKDNQLV VPADGLYLVY SQVLFKGQGC PDYVLLTHTV SRFAISYQEK VNLLSAVKSP CPKDTPEGAE LKPWYEPIYL GGVFQLEKGD QLSAEVNLPK YLDFAESGQV YFGVIAL |
| Molekylvikt (g/mol) | 17.3 kDa |
| Regulatorisk status | RUO |
| Formulering | protein with no preservative |
| För användning med (applikation) | ELISA,Functional Assay,Western Blot |
| Konjugera | Unconjugated |
| Renhet eller kvalitetsklass | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Gen-ID (Entrez) | 21926 |
| Tillträdesnummer | P06804 |
11
| Innehåll och lagring | -20°C |
|---|---|
| Källa | E. coli |
| Rekombinant | Recombinant |
| Form | Lyophilized |
| Biologisk aktivitet | Determined by its dose-dependent ability to induce reporter gene in HT-29 NF-kappaB Luc reporter cells. |
| Endotoxinkoncentration | <1 EU/ μg |
| Vanligt namn | RANKL (RANK Ligand) |
| Gensymbol | TNFSF11 |
| Namn | Human TRANCE (RANKL) (soluble) |
| Uttryckssystem | E. coli |
| Gene Alias | CD254; H-RANK-L; hRANKL2; Ly109l; M-Rank-L; ODF; OPG; OPG ligand; OPGL; OPTB2; Osteoclast differentiation factor; osteoprotegerin ligand; Rankl; rank-l; receptor activator of NF-kappaB ligand; receptor activator of nuclear factor kappa B ligand; receptor activator of nuclear factor kappa-B ligand; RP11-86N24.2; sOdf; srankl; TNF-related activation-induced cytokine; Tnfsf11; TNLG6B; Trance; tumor necrosis factor (ligand) superfamily member 11; tumor necrosis factor (ligand) superfamily, member 11; tumor necrosis factor ligand 6 B; tumor necrosis factor ligand superfamily member 11; Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form; tumor necrosis factor superfamily member 11; tumor necrosis factor-related activation-induced cytokine |
| Sekvens | MEKAMVDGSW LDLAKRSKLE AQPFAHLTIN ATDIPSGSHK VSLSSWYHDR GWAKISNMTF SNGKLIVNQD GFYYLYANIC FRHHETSGDL ATEYLQLMVY VTKTSIKIPS SHTLMKGGST KYWSGNSEFH FYSINVGGFF KLRSGEEISI EVSNPSLLDP DQDATYFGAF KVRDID |
| Molekylvikt (g/mol) | 20 kDa |
| Regulatorisk status | RUO |
| Formulering | protein with no preservative |
| För användning med (applikation) | ELISA,Functional Assay,Western Blot |
| Konjugera | Unconjugated |
| Renhet eller kvalitetsklass | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Gen-ID (Entrez) | 8600 |
| Tillträdesnummer | O14788 |
12
| Innehåll och lagring | -20°C |
|---|---|
| Rekombinant | Recombinant |
| Form | Lyophilized |
| Biologisk aktivitet | Determined by a cell proliferation assay using Balb/c 3T3 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Endotoxinkoncentration | <0.1 EU/ μg |
| Vanligt namn | FGF2 |
| Gensymbol | FGF2 |
| Namn | Human FGF-basic (FGF-2/bFGF) (154 aa), Animal-Free |
| Formatera | Lyophilized |
| Uttryckssystem | E. coli |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Sekvens | AAGSITTLPA LPEDGGSGAF PPGHFKDPKR LYCKNGGFFL RIHPDGRVDG VREKSDPHIK LQLQAEERGV VSIKGVCANR YLAMKEDGRL LASKCVTDEC FFFERLESNN YNTYRSRKYT SWYVALKRTG QYKLGSKTGP GQKAILFLPM SAKS |
| Reningsmetod | HPLC, SDS-PAGE |
| Molekylvikt (g/mol) | 17.2 kDa |
| Regulatorisk status | RUO |
| Formulering | protein with no preservative |
| Produkttyp | Protein |
| Aktivitet | Determined by a cell proliferation assay using Balb/c 3T3 cells. The expected ED50 is ≤ 0.1 ng/mL, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| För användning med (applikation) | Functional Assay |
| Konjugera | Unconjugated |
| Renhet eller kvalitetsklass | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Gen-ID (Entrez) | 2247 |
| Tillträdesnummer | P09038 |
13
Kampanjer är tillgängliga
Gibco™ Human/Mouse/Rat Activin A Recombinant Protein, PeproTech®
![]()
Gibco™ Human/Mouse/Rat Activin A Recombinant Protein, PeproTech®
Recombinant Protein
| Källa | CHO cells |
|---|---|
| Rekombinant | Recombinant |
| Form | Lyophilized |
| Gensymbol | Inhba |
| Namn | Human/Mouse/Rat Activin A |
| Gene Alias | activin A; activin beta-A chain; BMP7; BMP-7; Bone morphogenetic protein 7; EDF; Eptotermin alfa; erythroid differentiation factor; erythroid differentiation protein; follicle-stimulating hormone-releasing protein; FRP; FSH-releasing protein; INHB; Inhba; inhibin B subunit; inhibin beta A chain; inhibin beta A protein; inhibin beta A subunit; inhibin beta-A; inhibin beta-A-subunit; inhibin beta-subunit; inhibin subunit beta A; inhibin, beta A; inhibin, beta A (activin A, activin AB alpha polypeptide); Inhibin, beta-1; OP1; OP-1; Osteogenic protein 1; unnamed protein product |
| Sekvens | GLECDGKVNI CCKKQFFVSF KDIGWNDWII APSGYHANYC EGECPSHIAG TSGSSLSFHS TVINHYRMRG HSPFANLKSC CVPTKLRPMS MLYYDDGQNI IKKDIQNMIV EECGCS |
| Regulatorisk status | RUO |
| Formulering | Protein with no preservative |
| För användning med (applikation) | Control,Bioactivity |
| Konjugera | Unconjugated |
| Renhet eller kvalitetsklass | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Gen-ID (Entrez) | 16323, 29200, 3624 |
| Tillträdesnummer | P08476, P18331, Q04998 |
14
15
R&D Systems™ Recombinant Human FGF basic/FGF2/bFGF (146 aa) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity